Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection

Long-term effect of Direct-acting antivirals (DAAs) on gut microbiota, short-chain fatty acids (SCFAs) and microbial translocation in patients with hepatitis C virus (HCV) infection who achieve sustained virological response (SVR) were limited. A longitudinal study of 50 patients with HCV monoinfect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuaypen, Natthaya, Jinato, Thananya, Avihingsanon, Anchalee, Nookaew, Intawat, Tanaka, Yasuhito, Tangkijvanich, Pisit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475021/
https://www.ncbi.nlm.nih.gov/pubmed/37660163
http://dx.doi.org/10.1038/s41598-023-41664-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475021/
https://www.ncbi.nlm.nih.gov/pubmed/37660163
http://dx.doi.org/10.1038/s41598-023-41664-7

Ejemplares similares